Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hormonally Balanced vs Primary Clinic (Direct GLP)

Hormonally Balanced
Graded #412

Lower grade

vs+9.100000000000001
Primary Clinic (Direct GLP)
Graded #219

Higher grade

The verdict

Primary Clinic (Direct GLP) takes it — 65.5/100 to 56.4/100.

Primary Clinic (Direct GLP) grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePrimary Clinic (Direct GLP) +20
45
65
Dose & formulationPrimary Clinic (Direct GLP) +14
40
54
Clinical oversightHormonally Balanced +5
80
75
Labs & monitoringPrimary Clinic (Direct GLP) +23
53
76
FulfillmentEven
73
73
Contract termsHormonally Balanced +14
55
41
Hormonally Balanced · left barPrimary Clinic (Direct GLP) · right bar

The numbers

MetricHormonally BalancedPrimary Clinic (Direct GLP)
WeighScore56.4/10065.5/100
GradeCC
Scorecard rank#412#219
SemaglutideNot disclosed$85/mo (0.25-0.75 mg band, membership required, compounded)
TirzepatideNot disclosed$133/mo (1.25-2.5 mg band, membership required, compounded)
CoverageAll 50 states10 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Hormonally Balanced

Graded #412 · C

Strengths

  • Physician-led women's hormone clinic with concierge model
  • Nationwide telehealth availability
  • Semaglutide integrated with hormone care for women
  • Named physician (Dr. Zachareas) oversees prescriptions

Where it loses points

  • No pricing published online; must call or submit a form
  • Weight loss is secondary to menopause/hormone focus
  • Semaglutide only; no tirzepatide listed
  • Compounded vs brand formulation not disclosed

Strengths

  • Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
  • GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
  • Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
  • Routine labs and thousands of medications included in membership — no surprise bills
  • Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide

Where it loses points

  • The medication price is on top of an $89/mo direct-primary-care membership, which the FAQ states does not include the drug — all-in is about $174/mo for semaglutide and $222/mo for tirzepatide
  • Prices are published as dose BANDS rather than per dose, and the cheapest tirzepatide band starts at 1.25 mg, below the 2.5 mg labelled starting dose
  • The pricing is rendered entirely in JavaScript, so nothing on the page is readable without running the site's bundle
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard